UNSPSC 51172182: Tiropramide hydrochloride

This classification denotes a parasympatholytic and tyrosine analog C28H41N3O3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9523013Y6R, chemically known as benzenepropanamide, alpha-(benzoylamino)-4-(2-(diethylamino)ethoxy)- n,n-dipropyl-, hydrochloride, (+/-)-, but more generally known as tiropramide hydrochloride, which bears US NIH Compound Identifier 134448. European Medicines Agency schedules Tiropramide hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15577MIG.

Most nations, for tariff and trade purposes, schedule tiropramide hydrochloride under HS 29242995 and SITC 51479. As of Q4 2014, TIROPRAMIDE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CCCN(CCC)C(=O)C(CC1CCC(CC1)OCCN(CC)CC)NC(=O)C2CCCCC2.CL.

UNSPSC 51172182 Tiropramide hydrochloride is a Commodity code that, based on recent state and local solicitations, does not map to pharmaceutical procurement. The single recent opportunity posted under this code—Collin County Community Supervision and Corrections Department's RFP 2026-327 for offender specimen collection and drug testing services—involves laboratory testing infrastructure, staffing, and analytical methodologies (immunoassay screening, LC/MS/MS, GC/MS confirmation, oral fluid and hair testing) rather than the purchase or supply of tiropramide hydrochloride itself. The mismatch between the code's nominal pharmaceutical scope and the actual work being solicited suggests either a tagging error in the source or that this code rarely captures relevant state and local procurement activity.

Collin County's RFP 2026-327, due July 23, 2026, sought proposals for operation of two specimen collection sites in Plano and McKinney, an Interactive Voice Response system for randomized testing notifications, and lab-certified drug screening and confirmation testing on a per-test basis. The estimated contract value was $600,000 over two years with three optional one-year renewal periods, funded through Texas Department of Criminal Justice appropriations. Pricing was structured as per-test fees across three service models (screening only, confirmation after screening, and screening with automatic confirmation), with evaluation weighted toward vendor understanding (30 points), firm qualifications (25 points), client references (15 points), and cost (30 points). The anticipated award date was August 10, 2026. No other state or local opportunities under this code appear in the recent activity block, limiting visibility into geographic distribution or issuing-body patterns.